Published in:

01-03-2006 | ORIGINAL CONTRIBUTION

Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder

Authors: Philip Hazell, Ph.D., F.R.A.N.Z.C.P., Shuyu Zhang, M.S., Tomasz Wolańczyk, M.D., Ph.D., Joanne Barton, M.R.C.Psych., Mats Johnson, M.D., Alessandro Zuddas, M.D., Marina Danckaerts, M.D., Ph.D., Andrula Ladikos, M.Med., David Benn, M.Med., Roni Yoran-Hegesh, M.D., Pal Zeiner, M.D., David Michelson, M.D.

Published in: European Child & Adolescent Psychiatry | Issue 2/2006